Applied Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 11.50 M | $9.85 M | 904.37% | 79.67% |
| VR ADVISER, LLC | 02/14/2025 | 9.99 M | $8.55 M | 1.69% | 69.21% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 9.62 M | $8.23 M | 46.40% | 66.61% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 9.30 M | $7.96 M | 33.90% | 64.40% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 8.76 M | $7.50 M | 2,458.26% | 60.70% |
| KNOLL CAPITAL MANAGEMENT, LLC | 02/18/2025 | 5.80 M | $4.96 M | 4.04% | 40.18% |
| VANGUARD GROUP INC | 02/11/2025 | 5.55 M | $4.75 M | 5.82% | 38.44% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 5.42 M | $4.64 M | 2,511.86% | 37.56% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 4.47 M | $3.84 M | 0.69% | 30.95% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 2.82 M | $2.41 M | 0.00% | 19.52% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 2.71 M | $2.32 M | 175.80% | 18.76% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.43 M | $2.08 M | -11.06% | 16.82% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.08 M | $1.78 M | -0.36% | 14.44% |
| STATE STREET CORP | 02/14/2025 | 2.07 M | $1.77 M | -44.07% | 14.32% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 2.00 M | $1.72 M | -70.54% | 13.88% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.96 M | $1.68 M | -52.30% | 13.59% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 1.95 M | $1.67 M | 15,680.91% | 13.51% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.92 M | $1.64 M | 9.78% | 13.28% |
| SIREN, L.L.C. | 02/14/2025 | 1.63 M | $1.40 M | 0.00% | 11.32% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.33 M | $1.14 M | 379.20% | 9.21% |
| MARSHALL WACE, LLP | 02/13/2025 | 1.31 M | $1.12 M | 144.83% | 9.06% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.02 M | $874,700 | 24.93% | 7.08% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 860,000 | $736,332 | -89.26% | 5.96% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 700,836 | $600,056 | -4.68% | 4.86% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 556,001 | $476,048 | 1,542.50% | 3.85% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 530,324 | $453,957 | 0.02% | 3.67% |
| UBS GROUP AG | 02/14/2025 | 441,769 | $378,154 | 55.73% | 3.06% |
| WINDSOR ADVISORY GROUP, LLC | 02/14/2025 | 416,757 | $356,827 | 109.44% | 2.89% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 321,312 | $275,107 | 100.61% | 2.23% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 313,355 | $268,295 | 18.08% | 2.17% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 293,810 | $251,560 | 100.00% | 2.04% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 281,028 | $240,617 | 7.50% | 1.95% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 276,700 | $236,911 | 100.00% | 1.92% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 257,277 | $220,280 | 4.39% | 1.78% |
| 02/14/2025 | 254,019 | $217,491 | 100.00% | 1.76% | |
| NORGES BANK | 02/12/2025 | 243,200 | $208,228 | 100.00% | 1.68% |
| HRT FINANCIAL LP | 02/14/2025 | 242,878 | $207,000 | 100.00% | 1.68% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 237,850 | $203,647 | 17.77% | 1.65% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 204,400 | $175,007 | 104.40% | 1.42% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 191,800 | $164,219 | 91.80% | 1.33% |
| FMR LLC | 02/13/2025 | 176,036 | $150,722 | 7,231.78% | 1.22% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 174,651 | $149,536 | 29.11% | 1.21% |
| XTX TOPCO LTD | 02/13/2025 | 173,568 | $148,609 | 177.98% | 1.20% |
| BARCLAYS PLC | 02/13/2025 | 172,015 | $147,000 | -14.00% | 1.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 168,700 | $145,082 | -62.39% | 1.17% |
| ARISTIDES CAPITAL LLC | 02/13/2025 | 156,507 | $134,001 | 100.00% | 1.08% |
| SWISS NATIONAL BANK | 02/10/2025 | 146,900 | $125,776 | 100.00% | 1.02% |
| RHUMBLINE ADVISERS | 01/30/2025 | 134,335 | $114,982 | 0.74% | 0.93% |
| JANE STREET GROUP, LLC | 02/14/2025 | 130,300 | $111,563 | 146.78% | 0.90% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 120,000 | $102,744 | 0.33% | 0.83% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Applied Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 164 institutional investors and hedge funds held shares of Applied Therapeutics, Inc.. The most heavily invested institutionals were:
Vestal Point Capital, LP: 11.5 M
VR Adviser, LLC: 9.99 M
Propel Bio Management, LLC: 9.62 M
BlackRock Funding, Inc. /DE: 9.3 M
Schonfeld Strategic Advisors LLC: 8.76 M
Knoll Capital Management, LLC: 5.8 M
797.38% of Applied Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 122.50 M shares in the last 24 months. This purchase volume represents approximately $106.58 M in transactions.